Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

European Research Council grants worth more than €16.3 million have today been awarded to eight University of Oxford researchers for a range of cutting-edge projects.

Oxford skyline

The highly-competitive awards, given to Europe’s most innovative, high-impact academics, have been won by researchers from across the university’s four divisions - representing the highest number of consolidator grants awarded in the UK. These coveted prizes are awarded by the ERC to researchers with between seven and 12 years’ post-doctoral experience, ‘all selected solely based on excellence’, according to Mariya Gabriel, European Commissioner for Innovation, Research, Culture, Education and Youth.

Professor Patrick Grant, Pro-Vice-Chancellor for Research at the University of Oxford said: ‘These ERC awards are a strong endorsement of the quality and adventure of the research proposed by early and mid-career researchers across the University, in diverse subjects including demography, history, zoology, biology and chemistry.’

Oxford’s winners, each awarded research funding of some €2 million, include Dr Alfredo Castello in the Department of Biochemistry. A specialist in researching the role of RNA-binding proteins in virus infection, Dr Castello’s work has uncovered dozens of RBPs, which are crucial for viruses. Millions of people die each year from RNA viruses.  It is critical to understand the interactions that viruses establish with the host cell.

The full story is available on the University of Oxford website

Similar stories

RECOVERY trial team awarded MRC Impact Prize for Outstanding Team Impact

The Medical Research Council Prize Committee has awarded the RECOVERY trial team the MRC Impact Prize 2022 for Outstanding Team Impact.

Professor Sir Chris Whitty brings greater understanding of epidemics to Oxford

Chief Medical Officer of England Professor Sir Chris Whitty KCB FMedSci delivers the Sherrington Prize Lecture: Public Understanding of Science to an audience of Oxford staff and students.

Multiple Debilitating Pains – New global study shows the experience of Endometriosis is rooted in a person’s genetics

Researchers at the University of Oxford in collaboration with 25 teams across the world have published the largest study to date of the genetic basis of endometriosis.

Study shows delaying treatment for localised prostate cancer does not increase mortality risk

Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind.

Showcasing Oxford’s translational research for Rare Disease Day

Rare Disease Day is an annual awareness day that aims to educate and raise awareness for the 400 million people worldwide who live with a rare disease.

Prostate cancer AI diagnosis tool begins evaluation in Oxford

New artificial intelligence software that can help to spot prostate cancer is being trialled by researchers at Oxford University Hospitals (OUH) NHS Foundation Trust.